- Home
- WRAP vs AVTX Comparison
WRAP vs AVTX Comparison
Compare WRAP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- AVTX
- Stock Information
- Founded
- WRAP 2016
- AVTX 2011
- Country
- WRAP United States
- AVTX United States
- Employees
- WRAP N/A
- AVTX N/A
- Industry
- WRAP Ordnance And Accessories
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- AVTX Health Care
- Exchange
- WRAP Nasdaq
- AVTX Nasdaq
- Market Cap
- WRAP 104.2M
- AVTX 138.8M
- IPO Year
- WRAP N/A
- AVTX 2015
- Fundamental
- Price
- WRAP $2.14
- AVTX $11.33
- Analyst Decision
- WRAP
- AVTX Strong Buy
- Analyst Count
- WRAP 0
- AVTX 9
- Target Price
- WRAP N/A
- AVTX $30.14
- AVG Volume (30 Days)
- WRAP 385.1K
- AVTX 188.1K
- Earning Date
- WRAP 11-13-2025
- AVTX 11-06-2025
- Dividend Yield
- WRAP N/A
- AVTX N/A
- EPS Growth
- WRAP N/A
- AVTX N/A
- EPS
- WRAP N/A
- AVTX N/A
- Revenue
- WRAP $3,236,000.00
- AVTX $441,000.00
- Revenue This Year
- WRAP N/A
- AVTX N/A
- Revenue Next Year
- WRAP N/A
- AVTX N/A
- P/E Ratio
- WRAP N/A
- AVTX N/A
- Revenue Growth
- WRAP N/A
- AVTX N/A
- 52 Week Low
- WRAP $1.20
- AVTX $3.39
- 52 Week High
- WRAP $2.58
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- WRAP 70.76
- AVTX 62.61
- Support Level
- WRAP $1.62
- AVTX $9.54
- Resistance Level
- WRAP $2.11
- AVTX $12.41
- Average True Range (ATR)
- WRAP 0.18
- AVTX 1.05
- MACD
- WRAP 0.06
- AVTX -0.10
- Stochastic Oscillator
- WRAP 83.02
- AVTX 71.28
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).